Koninklijke Philips NV logo

Koninklijke Philips NV

PHIA#127 of 134 by buybacks

AS · Healthcare · Medical Devices · Netherlands

philips.com
Buybacks · FY2025€0≈ $0 · reported in EUR
Buyback yield0.0%repurchases ÷ market cap
Dividends · FY2025€328Mdividend yield 1.5%
Shareholder yield1.5%buybacks + dividends ÷ market cap
Shares outstanding · 5 yr+8.3%969M shares (2026)
Buybacks ÷ free cash flow0%payout incl. dividends 36%
Buybacks and dividends by fiscal year
Cash returned to shareholders, in EUR. Fiscal years end in December.
Shares outstanding
Share count up 8.3% over roughly five years. Falling is what a real buyback looks like.
Quarterly repurchases
Last 8 reported quarters, in EUR. Orange bars mark quarters where the company issued more shares than it bought.

Fiscal-year detail

From the cash-flow statement as reported, in EUR. Negative repurchases mean net share issuance.

Fiscal yearRepurchasesDividendsFree cash flow
FY2025Dec 2025€0€328M€903M
FY2024Dec 2024€411M€1.00M€893M
FY2023Dec 2023€662M€2.00M€1.49B
FY2022Dec 2022€187M€412M−€979M
FY2021Dec 2021€1.64B€482M€866M
FY2020Dec 2020€343M€1.00M€1.83B
FY2019Dec 2019€1.38B€453M€1.02B

Repurchases in FY2025 were −100.0% versus the prior year.

About Koninklijke Philips NV

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and s…

Market cap
€21.3B
P/E (trailing)
18.9×
Fiscal year end
December
ISIN
NL0000009538
Reporting currency
EUR
Data updated
Oct 9, 2026